Neonc Technologies (NASDAQ:NTHI) President Amir Heshmatpour Purchases 20,000 Shares

Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) President Amir Heshmatpour purchased 20,000 shares of Neonc Technologies stock in a transaction that occurred on Thursday, April 2nd. The stock was acquired at an average price of $6.09 per share, with a total value of $121,800.00. Following the transaction, the president owned 3,012,000 shares in the company, valued at $18,343,080. The trade was a 0.67% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Neonc Technologies Trading Down 3.5%

NTHI stock opened at $5.74 on Tuesday. The company has a fifty day moving average price of $8.87 and a 200 day moving average price of $9.22. Neonc Technologies Holdings, Inc. has a 12 month low of $3.20 and a 12 month high of $12.99.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on NTHI shares. Weiss Ratings restated a “sell (e+)” rating on shares of Neonc Technologies in a research report on Friday, March 27th. Zacks Research raised Neonc Technologies to a “hold” rating in a research note on Wednesday, January 14th. One equities research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Reduce”.

Hedge Funds Weigh In On Neonc Technologies

Several hedge funds have recently added to or reduced their stakes in the business. HighPoint Advisor Group LLC grew its holdings in shares of Neonc Technologies by 424.8% during the third quarter. HighPoint Advisor Group LLC now owns 950,232 shares of the company’s stock worth $8,628,000 after buying an additional 769,163 shares in the last quarter. Bank of America Corp DE purchased a new stake in shares of Neonc Technologies during the second quarter worth about $801,000. Vanguard Group Inc. purchased a new stake in shares of Neonc Technologies during the third quarter worth about $1,279,000. 683 Capital Management LLC purchased a new stake in shares of Neonc Technologies during the fourth quarter worth about $442,000. Finally, Global Retirement Partners LLC purchased a new stake in shares of Neonc Technologies during the third quarter worth about $434,000.

Neonc Technologies Company Profile

Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.